Opinions Chris Blumas
Assisted Living ConceptsALCWEAK BUYFeb 12, 2025
Chris BlumasUnknown
N/A
Stock price when the opinion was issued
$72.37
As of Nov 03, 2026. Market Open.
medical services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
European-based, but US operating platform. Contact lenses + surgical supplies (corrective procedures), each with 50% of revenues. Demographics is supportive even of eye health, and increased screen time also feeds into that. Reasonable valuation at 17x PE, 4-5% FCF yield.
Attractive, defensive business in this environment. Yield is 0.57%.
Chris BlumasOwned
biotechnologypharmaceutical
TOP PICK
Proad product array. Not widely followed. Very strong grower.
Thomas GalvinOwned
biotechnologypharmaceutical
He was looking at defensive healthcare names to avoid threat of tariffs. This is one name to consider, valuation slightly elevated, but unique capabilities in eye care.